|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Waubant E, Stuve O. 2002. Suspected mechanisms involved in multiple sclerosis and putative role of hepatitis B vaccine in multiple sclerosis. Commissioned Background Paper for IOM Immunization Safety Review Committee. Weed DL, Hursting SD. 1998. Biologic plausibility in causal inference: Current method and practice. Am J Epidemiol 147(5):415–25. Wise RP, Kiminyo KP, Salive ME. 1997. Hair loss after routine immunizations. JAMA 278(14):1176–8. Wucherpfennig KW. 2001. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 108(8):1097–104. Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. 2000. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA 284(8):978–83. Zinkemagel RM. 2001. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 345(18):1331–5. Zipp F, Weil JG, Einhaupl KM. 1999. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 5(9):964–5.
|
|
|||||||||||||||
